Cargando…
NIR‐Activated Polydopamine‐Coated Carrier‐Free “Nanobomb” for In Situ On‐Demand Drug Release
Carrier‐free nanoparticles with high drug loading have attracted increasing attention; however, in situ on‐demand drug release remains a challenge. Here, a novel near‐infrared (NIR) laser‐induced blasting carrier‐free nanodrug delivery system is designed and fabricated by coating doxorubicin (DOX) n...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051140/ https://www.ncbi.nlm.nih.gov/pubmed/30027047 http://dx.doi.org/10.1002/advs.201800155 |
_version_ | 1783340465026760704 |
---|---|
author | Li, Minghui Sun, Xuetan Zhang, Ning Wang, Wei Yang, Yang Jia, Huizhen Liu, Wenguang |
author_facet | Li, Minghui Sun, Xuetan Zhang, Ning Wang, Wei Yang, Yang Jia, Huizhen Liu, Wenguang |
author_sort | Li, Minghui |
collection | PubMed |
description | Carrier‐free nanoparticles with high drug loading have attracted increasing attention; however, in situ on‐demand drug release remains a challenge. Here, a novel near‐infrared (NIR) laser‐induced blasting carrier‐free nanodrug delivery system is designed and fabricated by coating doxorubicin (DOX) nanoparticles (DNPs) with a polydopamine film (PDA) that would prolong the blood circulation time of DNPs and avoid the preleakage of the DOX during blood circulation. Meanwhile, the NH(4)HCO(3) is introduced to trigger in situ “bomb‐like” release of DOX for the production of carbon dioxide (CO(2)) and ammonia (NH(3)) gases driven by NIR irradiated photothermal effect of PDA. Both in vitro and in vivo studies demonstrate that the carrier‐free nanovectors with high drug loading efficiency (85.8%) prolong tumor accumulation, enhance chemotherapy, achieve the synergistic treatment of chemotherapy and photothermal treatment, and do not induce any foreign‐body reaction over a three‐week implantation. Hence, the delicate design opens a self‐assembly path to develop PDA‐based NIR‐responsive multifunctional carrier‐free nanoparticles for tumor therapy. |
format | Online Article Text |
id | pubmed-6051140 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-60511402018-07-19 NIR‐Activated Polydopamine‐Coated Carrier‐Free “Nanobomb” for In Situ On‐Demand Drug Release Li, Minghui Sun, Xuetan Zhang, Ning Wang, Wei Yang, Yang Jia, Huizhen Liu, Wenguang Adv Sci (Weinh) Full Papers Carrier‐free nanoparticles with high drug loading have attracted increasing attention; however, in situ on‐demand drug release remains a challenge. Here, a novel near‐infrared (NIR) laser‐induced blasting carrier‐free nanodrug delivery system is designed and fabricated by coating doxorubicin (DOX) nanoparticles (DNPs) with a polydopamine film (PDA) that would prolong the blood circulation time of DNPs and avoid the preleakage of the DOX during blood circulation. Meanwhile, the NH(4)HCO(3) is introduced to trigger in situ “bomb‐like” release of DOX for the production of carbon dioxide (CO(2)) and ammonia (NH(3)) gases driven by NIR irradiated photothermal effect of PDA. Both in vitro and in vivo studies demonstrate that the carrier‐free nanovectors with high drug loading efficiency (85.8%) prolong tumor accumulation, enhance chemotherapy, achieve the synergistic treatment of chemotherapy and photothermal treatment, and do not induce any foreign‐body reaction over a three‐week implantation. Hence, the delicate design opens a self‐assembly path to develop PDA‐based NIR‐responsive multifunctional carrier‐free nanoparticles for tumor therapy. John Wiley and Sons Inc. 2018-05-09 /pmc/articles/PMC6051140/ /pubmed/30027047 http://dx.doi.org/10.1002/advs.201800155 Text en © 2018 The Authors. Published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Full Papers Li, Minghui Sun, Xuetan Zhang, Ning Wang, Wei Yang, Yang Jia, Huizhen Liu, Wenguang NIR‐Activated Polydopamine‐Coated Carrier‐Free “Nanobomb” for In Situ On‐Demand Drug Release |
title | NIR‐Activated Polydopamine‐Coated Carrier‐Free “Nanobomb” for In Situ On‐Demand Drug Release |
title_full | NIR‐Activated Polydopamine‐Coated Carrier‐Free “Nanobomb” for In Situ On‐Demand Drug Release |
title_fullStr | NIR‐Activated Polydopamine‐Coated Carrier‐Free “Nanobomb” for In Situ On‐Demand Drug Release |
title_full_unstemmed | NIR‐Activated Polydopamine‐Coated Carrier‐Free “Nanobomb” for In Situ On‐Demand Drug Release |
title_short | NIR‐Activated Polydopamine‐Coated Carrier‐Free “Nanobomb” for In Situ On‐Demand Drug Release |
title_sort | nir‐activated polydopamine‐coated carrier‐free “nanobomb” for in situ on‐demand drug release |
topic | Full Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051140/ https://www.ncbi.nlm.nih.gov/pubmed/30027047 http://dx.doi.org/10.1002/advs.201800155 |
work_keys_str_mv | AT liminghui niractivatedpolydopaminecoatedcarrierfreenanobombforinsituondemanddrugrelease AT sunxuetan niractivatedpolydopaminecoatedcarrierfreenanobombforinsituondemanddrugrelease AT zhangning niractivatedpolydopaminecoatedcarrierfreenanobombforinsituondemanddrugrelease AT wangwei niractivatedpolydopaminecoatedcarrierfreenanobombforinsituondemanddrugrelease AT yangyang niractivatedpolydopaminecoatedcarrierfreenanobombforinsituondemanddrugrelease AT jiahuizhen niractivatedpolydopaminecoatedcarrierfreenanobombforinsituondemanddrugrelease AT liuwenguang niractivatedpolydopaminecoatedcarrierfreenanobombforinsituondemanddrugrelease |